Published in Case Rep Dermatol Med on February 18, 2015
Pityriasis lichenoides: pathophysiology, classification, and treatment. Am J Clin Dermatol (2007) 1.16
Infliximab-induced pityriasis lichenoides chronica in a patient with psoriasis. J Eur Acad Dermatol Venereol (2008) 1.05
Dermatological adverse reactions during anti-TNF treatments: focus on inflammatory bowel disease. J Crohns Colitis (2013) 1.00
Current immunotherapy in rheumatoid arthritis. Immunotherapy (2013) 1.00
Cutaneous adverse events during treatment of chronic inflammatory rheumatic conditions with tumor necrosis factor antagonists: study using the Spanish registry of adverse events of biological therapies in rheumatic diseases. Arthritis Care Res (Hoboken) (2013) 0.99
Adverse cutaneous reactions induced by TNF-alpha antagonist therapy. South Med J (2009) 0.98
Etanercept: an overview of dermatologic adverse events. Arch Dermatol (2011) 0.87
Etanercept-induced injection site reactions: potential pathomechanisms and clinical assessment. Expert Opin Drug Saf (2012) 0.82
Pityriasis lichenoides chronica induced by adalimumab therapy for Crohn's disease: report of 2 cases successfully treated with methotrexate. Inflamm Bowel Dis (2010) 0.82
Pityriasis lichenoides chronica induced by infliximab, with response to methotrexate. Eur J Dermatol (2010) 0.81
Pneumocystis jirovecii Pneumonia in a Patient with Rheumatoid Arthritis Treated with Abatacept. Case Rep Rheumatol (2014) 0.75
Rituximab for remission induction and maintenance in refractory systemic lupus erythematosus. Autoimmune Dis (2014) 0.75